Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityJohn W. Shiver, Rima Youil, Tong‐Ming Fu et al.|Nature|2002Cited by 1.2k
Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV VaccineMyron J. Levin, Michael J. Caulfield, Jeffrey G. Smith et al.|The Journal of Infectious Diseases|2003Cited by 320
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysJohn W. Shiver, Xiaoping Liang, Melanie Horton et al.|Vaccine|2004Cited by 315
Solution State Characterization of Amyloid β-Derived Diffusible LigandsRobert W. Hepler, Joseph G. Joyce, Mark D. Yeager et al.|Biochemistry|2006Cited by 183